Home > Press > CRANN launches Public Report 2009-2010
Abstract:
The Science Foundation Ireland funded centre CRANN has launched its public report for 2009 - 2010 today. The report highlights that CRANN, a Trinity College Dublin Institute founded in 2004, has continued to establish itself as a national and international force in nanoscience and nanotechnology research and collaborative industry engagement. The institute has achieved a number of key milestones including a significant expansion of its industry engagement programme, significant non-exchequer investment and international validation for its world class research.
Commenting at the launch, Dr. Diarmuid O'Brien, Executive Director, CRANN, said, "CRANN is now demonstrating how world class research can lead to the generation of intellectual property that has an impact in the real economy, resulting in job creation, company formation and technology exports. The investment in research excellence by SFI has established CRANN as a leading nanoscience research centre on the international stage and ultimately led to economic return for Ireland. In order to continue to attract foreign direct investment to Ireland, it is vital that we continue to invest in research."
Since mid 2008 CRANN has published over 270 papers. The quality of these publications have been independently verified by a Thomson-Reuters report in 2010 which placed Ireland 8th globally for materials science research based on citations per publication for the decade 2000 - 2010. CRANN researchers were responsible for more than 70% of these outputs leading to this national ranking.
"Our reputation for excellence in fundamental research has enabled strong industry engagement" said O'Brien. "We are now working with 74 companies including industry giants like Intel and HP, helping them develop next generation technologies by acting as an innovation engine. We also work with a range of indigenous Irish companies, such as Aerogen and Eblana Photonics, helping them develop new products and services. Furthermore, we are producing high calibre graduates who are laying the foundation for Ireland's development into a Smart Economy."
Two Companies have been spun out by CRANN PIs - Glantreo and Miravex. Glantreo recently signed a $10 million deal to supply silica based materials to a US company specialising in chromatography and chemical separations. Miravex was awarded the first eircom University Challenge Award at the Irish Technology Leadership Forum.
CRANN has secured €8.7 million in non-exchequer funding from international competitive research programmes and industry. CRANN is presently leading two large collaborative programmes and is participating in another 11. The institute is collaborating with over 60 universities and 40 companies through European Framework programmes.
Since 2008, CRANN researchers have made 37 invention disclosures, 21 patent applications across international territories with four patents granted, and have had two licenses negotiated.
As part of its continued success, CRANN acknowledges the vital support from key national funding agencies Science Foundation Ireland, Enterprise Ireland and the Higher Education Authority, in addition to the support of Trinity College Dublin.
####
For more information, please click here
Copyright © Trinity College Dublin
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
View Full Report here (10MB in size)
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Research partnerships
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||